miR-181a在肾透明细胞癌中的表达及对肾透明细胞癌细胞786-O功能的影响

Expression of miR-181a in human clear cell renal carcinoma and its effect on biological behavior of clear cell renal carcinoma 786-O cells

  • 摘要: 目的 探讨miR-181a在肾透明细胞癌中的表达及miR-181a对肾透明细胞癌细胞系786-O功能的影响。 方法 通过qRT-PCR的方法检测miR-181a在42对肾透明细胞癌肿瘤及瘤旁组织和细胞系786-O、769-P、A498、Caki-1中的表达水平;以miR-181a mimics、miR-181a inhibitor转染786-O细胞系,通过MTS实验观察其增殖能力的改变,并通过流式细胞仪检测细胞周期及细胞凋亡的变化。 结果 miR-181a在肾透明细胞癌中的表达明显高于瘤旁组织,同时其在细胞系786-O、769-P、A498、Caki-1中的表达明显高于其在人肾小管上皮细胞HKC中的表达。在786-O细胞系中,转染miR-181a mimics可以明显促进其增殖,诱导G1/S期转换并抑制凋亡;而miR-181a inhibitor则抑制增殖,诱导G1期阻滞并促进凋亡。 结论 miR-181a在肾透明细胞癌中高表达并参与肿瘤的发生和发展,提示miR-181a可能成为肾癌治疗的潜在靶点。

     

    Abstract: Objective To investigate the expression of miR-181a in patients with clear cell renal carcinoma (ccRCC) and its effect on biological behaviors of human ccRCC cell line 786-O. Methods The expression of miR-181a in 42 tumor tissues and paired adjacent normal tissues of ccRCC, and ccRCC cell lines 786-O, 769-P, A498, caki-1 were detected by qRT-PCR. Chemically synthesized miR-181a mimics or inhibitor were transfected into ccRCC cell line 786-O, then its proliferation was observed by MTS assay and its cell cycle and apoptosis were detected by flow cytometric analysis. Results Compared with adjacent noncancerous tissues, miR-181a expression increased significantly in ccRCC tissues, and it was also significantly higher in cell lines 786-O, 769-P, A498, caki-1 than in human kidney tubule epithelial cell (HKC). miR-181a mimics significantly promoted cell proliferation, G1/S transition in cell cycle and inhibited cell apoptosis in ccRCC cell line 786-O, however, miR-181a inhibitor significantly inhibited cell proliferation, arrested cells in G1 phase while promoted cell apoptosis. Conclusion The miR-181a expresses highly in ccRCC and also participates in the occurrence and development of tumor, which may be a valuable prognostic predictor and a potential therapeutic target of ccRCC.

     

/

返回文章
返回